Provida OB By US Pharmaceutical Corporation Overview & Drug Interactions

Check For Interactions With Provida OB

Supplement: Provida OB by US Pharmaceutical Corporation

Provida OB Label Images

This product contains

Below is a list of the 'active' ingredients listed on the supplement label for this product.

For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.

Drugs that interact with Provida OB by US Pharmaceutical Corporation

Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.

Label Information

Supplement Facts:

Daily Value (DV) Target Group(s): Adults and children 4 or more years of age
Minimum serving Sizes:
1 Capsule(s)
Maximum serving Sizes:
1 Capsule(s)
Servings per container 30
UPC/BARCODE 352747504304

Ingredient Amount per Serving Group % DV, Adults & children 4+ years
Vitamin C
60 mg
Vitamin C 67% 50%
Vitamin D3
10 mcg
Vitamin D 50% 67%
Vitamin B1
2.5 mg
Thiamin 208% 179%
Vitamin B2
3.5 mg
Riboflavin 269% 219%
Vitamin B3
10 mg
Niacin 63% 56%
Vitamin B6
25 mg
Vitamin B6 1471% 1250%
Folic Acid
1.25 mg
Folate 313% 208%
Vitamin B12
12 mcg
Vitamin B12 500% 429%
Biotin
300 mcg
Biotin 1000% 857%
Pantothenic Acid
6 mg
Vitamin B5 120% 86%
Iron
40 mg
Iron 222% 148%
Ferrous Fumarate
20 mg
Iron
Polysaccharide Iron Complex
20 mg
Iron
Magnesium
20 mg
Magnesium 5% 5%
Zinc
10 mg
Zinc 91% 77%
Copper
1 mg
Copper 111% 77%
Lactobacillus casei KE-99
30 mg
Lactobacillus casei -- --

Other Ingredients:
Titanium Dioxide
FD&C Blue #1
FD&C Red #40
Hypromellose
Magnesium Stearate
Microcrystalline Cellulose


Label Statments:


General Statements
- Rx only
- Clinical Studies: Picinni, L.-Ricciotti, M. 1982. Therapeutic effectiveness of an iron-polysaccharide complex in comparison with iron fumarate in the treatment of iron deficiency anemias: PANMINERVA MEDICA-EUROPA MEDICA, Vol. 24, No. 3, pp. 213-220 (July-September 1982).
- The listed product number is not a National Drug Code. Instead, US Pharmaceutical Corporation has assigned this product code formatted according to standard industry practice to meet the formatting requirements of pharmacy and healthcare insurance computer systems.
- Consult package literature for full prescription information. Manufactured with Vcaps Plus capsule shells.
- Lift here for full prescription information
FDA Statement of Identity
- Prenatal Multivitamin & Mineral Supplement Enhanced with Lactobacillus casei KE-99
Formula
- Prenatal Multivitamin & Mineral Supplement enhanced with Lactobacillus casei KE-99
- Indications: Provida OB is a prenatal supplement designed to improve the nutritional status of women throughout pregnancy and during the postnatal period to lactating and non-lactating mothers. Provida OB may also be used to improve the nutritional status of women before conception.
- Ferrous Fumarate and Polysaccharide Iron Complex (PIC): All Provida products include a unique patented source of iron, e.g. Ferrous Fumarate and Polysaccharide Iron Complex (U.S. Patent No: 11/243,043 Pending). "An increase in tolerability is observed with the formulation and is believed to occur as the result of distributing the total iron content in the composition among compounds that provide iron to the patient's blood stream via two different mechanisms. The ferrous salts are readily absorbed in the upper gut, by direct dissolution and absorption of the ferrous iron by the bloodstream. However, the iron available from PIC is absorbed in the lower gut, via an active protein transport mechanism".
- Folic acid: Folic acid is one of the important hematopoietic agents necessary for proper regeneration of the blood-forming elements and their function. Additionally, folic acid increases jejunal glycolytic enzymes and is involved in the desaturation and hydroxylation of long-chain fatty acids in the brain. A deficiency in folic acid results in megaloblastic anemia.
Precautions
- Contraindications: Provida OB is contraindicated in patients with known hypersensitivity to any of its ingredients; also, all iron compounds are contraindicated in patients with hemosiderosis, hemochromatosis, or hemolytic anemias. It is also contraindicated in patients suffering from pernicious anemia as folic acid may obscure its signs and symptoms.
- Warning: Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where Vitamin B12 is deficient. Precautions: Folic acid in doses above 0.1 mg - 0.4 mg daily may obscure the signs and symptoms of pernicious anemia, in that hematological remission can occur while neurological manifestations remain progressive. The use of this product by immunocompromised patients or treatment of any disorder must be medically supervised by a physician.
- Overdose: Iron: Signs and Symptoms: Iron is toxic. Acute overdosage of iron may cause nausea and vomiting and, in severe cases, cardiovascular collapse and death. Other symptoms include pallor and cyanosis, melena, shock, drowsiness and coma. The estimated overdose of orally ingested iron is 300-mg/kg body weight. When overdoses are ingested by children, severe reactions, including fatalities, have resulted.
- Do not administer to children under the age of 12.
- Caution: Rx only.
- Warning: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.
- You should contact your healthcare provider for medical advice about adverse events. To report a serious adverse event, contact US Pharmaceutical Corporation, P.O. Box 360465, Decatur, GA 30036.
- Packed in child resistant cap and light resistant bottle of 30 capsules (52747-0504-30).
Suggested/Recommended/Usage/Directions
- Dosage and administration: Adults (persons over 12 years of age), one (1) capsule daily, between meals, or as prescribed by a physician. Do not exceed recommended dosage. Do not administer to children under the age of 12.
FDA Disclaimer Statement
- These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
Storage
- Store at room temperature 15 degrees to 30 degrees C (59 degrees to 86 degrees F) and dry place.
Formulation
- Manufactured in a FDA registered facility in the USA.
- HOW supplied: Provida OB™ are swedish orange opaque Vcaps® capsules printed in white "US" Logo on the cap and “ProV” on the body.
Brand IP Statement(s)
- Patent Numbers: USA: 6,797,266; 5,626,883; Mexico MX/a/2008/004461; Singapore: 200802623-9 and other countries. Vcaps and the Vcaps Logo are trademarks used under license.

Brand Information

See all products by this brand

Marketed by
Name US Pharmaceutical Corporation
Street Address P.O. Box 360465
City Decatur
State GA
ZipCode 30036

Return to the main supplement interaction checker page

Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Drug descriptions are provided by MedlinePlus.